Bissoy.com
Doctors Medicines MCQs Q&A

  1. Serum Institute
  2. Bharat Biotech
  3. Dr. Reddy's Laboratories
  4. Zydus Cadila
5 views

1 Answers

Option 2 : Bharat Biotech

The correct answer is Bharat Biotech.

  • Bharat Biotech received approval by DCGI to conduct a phase III clinical trial of an intranasal booster dose of Covid-19.
  • An intranasal vaccine reduces the use of needles and syringes, among others, and is easy to administer.
  • Bharat Biotech will conduct a phase-3 randomized multi-focused clinical study to evaluate the immunogenicity and safety of its intranasal vaccine as a booster dose on participants who were previously vaccinated with an approved COVID-19 vaccine.

  • DCGI: Drugs Controller General of India
    • It is the head of the department of the Central Drugs Standard Control Organization of the Government of India.
    • it is responsible for the approval of licenses of specified categories of drugs such as blood and blood products, IV fluids, vaccines, and sera in India.
    • Headquarters: New Delhi.​
Company Founded Founder Headquarter About
Bharat Biotech 1996 Krishna Ella Hyderabad Indian multinational biotechnology company.
Serum Institute 1966 Cyrus S. Poonawalla Pune Indian biotechnology and biopharmaceuticals company
Dr. Reddy's Laboratories 1984  Kallam Anji Reddy Hyderabad Indian multinational pharmaceutical company
Zydus Cadila 1952 Ramanbhai Patel Ahmedabad

It is formerly known as Cadila Healthcare Limited.

Indian multinational pharmaceutical company.
5 views

Related Questions

In the question below, are given a statement followed by three courses of actions numbered I, II and III. On the basis of the information given, you have to assume everything in the statement to be true, and then decide which of the suggested courses of action logically follow(s) for pursuing. Statement: India may become the second largest smartphone selling country in the world if the sales continue to grow at the current pace, said Raghu Reddy, head of category and online sales of Xiaomi India. Smartphone sales in 2017 grew around 10% in the country in 2017. "India could overtake the US market and become the second largest smartphone market globally after China at this rate of growth’,’ Reddy said adding that currently the growth is happening in the Rs. 10,000 to 20,000 price range.  Courses of action: I. Xiaomi, is currently the largest selling smartphone in the country with a growth of over 300% in 2017. It currently has a market share of over 30% including online and offline sales.  II. The company has ramped up its production facilities in the recent times in the country and now has six production facilities spread over Andhra Pradesh, Tamil Nadu and Uttar Pradesh.  III. Now the printed circuit board assembly (PCBA) used in smartphone, which accounts for 50% of the value of the phone, will be made in India?
1 Answers 5 Views
Match List I with List II: List I (Method) List II (Purchase consideration) (A) Lump-sum payment method (I) Calculated by adding up the total amount (money value) of existing shares, preference shares and cash received from the purchasing company for the shareholders of the vendor company. (B) Net Assets Method (II) On the basis of ratio in which the shares of the transferee company are to be exchanged for the shares of the transferor company. (C) Net Payment Method (III) The amount to be paid by the transferee company to transferor company for amalgamation of its business. (D) Swap Ratio Method (IV) Arrived at by adding the agreed value of assets taken over and deducting there from the agreed values of liabilities. Choose the correct answer from the options given below:?
1 Answers 7 Views